COUGH is the #9 most commonly reported adverse reaction for ACLIDINIUM BROMIDE, manufactured by Covis Pharma US, Inc. There are 655 FDA adverse event reports linking ACLIDINIUM BROMIDE to COUGH. This represents approximately 2.4% of all 27,417 adverse event reports for this drug.
Patients taking ACLIDINIUM BROMIDE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH655 of 27,417 reports
COUGH is a less commonly reported adverse event for ACLIDINIUM BROMIDE, but still significant enough to appear in the safety profile.
Other Side Effects of ACLIDINIUM BROMIDE
In addition to cough, the following adverse reactions have been reported for ACLIDINIUM BROMIDE:
COUGH has been reported as an adverse event in 655 FDA reports for ACLIDINIUM BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with ACLIDINIUM BROMIDE?
COUGH accounts for approximately 2.4% of all adverse event reports for ACLIDINIUM BROMIDE, making it a notable side effect.
What should I do if I experience COUGH while taking ACLIDINIUM BROMIDE?
If you experience cough while taking ACLIDINIUM BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.